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It is a commonly held belief that prostate carcinogenesis is a multi-stage process and that tumor invasion is trig-
gered by the overproduction of proteolytic enzymes. This belief is consistent with data from cell cultures and 
animal models, whereas is hard to interpret several critical facts, including the presence of cancer in “healthy” 
young men and cancer DNA phenotype in morphologically normal prostate tissues. These facts argue that al-
ternative pathways may exist for prostate tumor invasion in some cases. Since degradation of the basal cell layer 
is the most distinct sign of invasion, our recent studies have attempted to identify pre-invasive lesions with focal 
basal cell layer alterations. Our studies revealed that about 30% of prostate cancer patients harbored normal ap-
pearing duct or acinar clusters with a high frequency of focal basal cell layer disruptions. These focally disrupted 
basal cell layers had significantly reduced cell proliferation and tumor suppressor expression, whereas signifi-
cantly elevated degeneration, apoptosis, and infiltration of immunoreactive cells. In sharp contrast, associated 
epithelial cell had significantly elevated proliferation, expression of malignancy-signature markers, and physical 
continuity with invasive lesions. Based on these and other findings, we have proposed that these normal ap-
pearing duct or acinar clusters are derived from monoclonal proliferation of genetically damaged stem cells and 
could progress directly to invasion through two pathways: 1) clonal in situ transformation (CIST) and 2) 
multi-potential progenitor mediated “budding” (MPMB). These pathways may contribute to early onset of pros-
tate cancer at young ages, and to clinically more aggressive prostate tumors. 
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Introduction 
The normal prostate luminal cells, which are the 
histological origin of most prostate malignancies, are 
physically separated from the stroma by the basal cells 
and basement membrane (BM). Basal cells are joined 
by intercellular junctions and adhesion molecules, 
constituting a continuous sheet encircling luminal cells 
[1-2]. The BM is composed of type IV collagen, 
laminins, and other molecules, forming a continuous 
lining surrounding and attaching to the basal cell layer 
[3-4]. The epithelium is normally devoid of blood ves-
sels and lymphatic ducts, and totally relies on the 
stroma for its metabolic and even survival needs. Be-
cause of these structural relationships (Fig 1), the dis-
ruption of both the basal cell layer and the BM is a 
pre-requisite for prostate tumor invasion or metastasis. 
It is a commonly held belief that human prostate 
carcinogenesis is a multistage process, progressing 
sequentially from normal to hyperplasia, to prostatic 
intraepithelial neoplasia (PIN), and to invasive or me-
tastatic stages [5-8]. Progression from PIN to invasion 
is believed to be triggered by overproduction of pro-
teolytic enzymes primarily by cancer cells, which 
cause degradation of the BM [9-10]. These theories are 
consistent with results of studies in tissue cultures and 
animal models, whereas are hard to interpret the fol-
lowing critical facts:  
1. Our previous studies revealed that some 
healthy men between 19 and 29 years old had a spec-
trum of proliferative lesions, including hyperplasia, 
PIN, and incipient adenocarcinoma [11-13]. 
2. Recent studies detected a DNA phenotype that 
is identical to that of invasive prostate cancer in some 
“healthy” men, and in morphologically normal pros-
tate tissues adjacent to prostate cancer [14-17].  
3. A vast majority of PIN express high levels of 
proteolytic enzymes, while only 10-30% of untreated Int. J. Biol. Sci. 2008, 4 
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PIN progress to invasive lesions during patients’ life-
time [18-21]. Unfortunately, none of the current ap-
proaches could predict which PIN lesions will pro-
gress [22-25]. The only established approach to moni-
tor PIN progression is repeat biopsy [22-25], which is 
costly and painful. 
Together, these facts argue that alternative 
pathways may exist, because if the linear model of 
tumor progression and invasion is universally appli-
cable, the normal prostate tissues of healthy subjects 
should not harbor malignant structural abnormalities. 
Since over 90% of prostate cancer related mortality 
result from invasion-related illness, and the incidence 
of PIN could be up to 16.5%-25% in prostate biopsies 
[24-28], there is an urgent need to uncover the intrinsic 
mechanism of tumor invasion.  
Promoted by the fact that the basal cell layer is the 
sole source of tumor suppressor p63 and maspin 
[29-32], and that degradation of basal cell layers is a 
pre-requisite for tumor invasion, our resent studies 
have attempted to identify early signs of basal cell 
degradation. Our initial study examined the physical 
integrity of basal cell layers in 50 patients with 
co-existing pre-invasive and invasive prostate tumors. 
Of 2,047 ducts and acini examined, 197 were found to 
harbor focal disruptions (the absence of basal cells re-
sulting in a gap greater than the combined size of at 
least 3 basal cells) in their basal cell layers. The fre-
quency of focal basal cell layer disruptions (FBCLD) 
varied from none in 22 (44%) cases to over 1/3 of the 
ducts or acini with FBCLD in 17 (34%) cases (Table 1) 
[33].  
Table 1. Frequencies of focal basal cell layer disruptions among cases 
Case number    No disruptions  < 30% disruptions  ≥30% disruptions   p 
 50   22 (44%)    11 (22%)   17 (34%)   < 0.01 
 
 
 
Fig 1. Structural relationships among the epithelium (EP), basal cell layer (BCL), basement membrane (BM), and stroma (ST). 
Section was double immunostained for the BM (brown) and BCL (red). a: 100X b: a higher (300X) magnification a.  
 
Fig 2. Different frequencies of FBCLD among cases. Double immunostained for CK 34ßE12 (red) and Ki-67 (brown). In case 1 (a), 
all 12 acini show FBCLD (arrows), while in case 2 (b), none of the 12 acini shows FBCLD. 300X.  Int. J. Biol. Sci. 2008, 4 
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Of the 17 cases with a high frequency of FBCLD, 
the basal cell layer had several unique alterations that 
were not or rarely seen in their morphologically simi-
lar counterparts in other cases [33-44]: 
a. significantly reduced expression of tumor sup-
pressor p63: In sections double immunostained for p63 
and CK34ßE12, an average of 87% of the basal cells in 
non-disrupted layers expressed both molecules, while 
only 59% of the basal cells in focally disrupted layers 
had p63 expression (Fig 3; Table 2). 
Table 2. p63 expression in basal cell layers with and without 
focal disruption 
Basal cell layer 
status 
Number of ducts 
or acini 
 Percentage of p63 
(+) cells  
 P 
With disruption   197   59% 
W/o disruption   197   87% 
  
 < 0.01
 
b. significantly reduced expression of proliferat-
ing cell nuclear antigen (PCNA):  In sections double 
immunostained for PCNA and CK4ßE12, an average 
of 74% of the normal basal cells showed PCNA ex-
pression, but only 51% of basal cells in disrupted basal 
layers were PCNA positive (Fig. 4; Table 3). 
Table 3. PCNA expression in basal cell layers with and without 
focal disruption 
Basal cell layer 
status 
Number of ducts 
or acini 
 % of PCNA (+) 
cells 
 P 
With disruption   50   51% 
W/o disruption   50   74% 
 
 < 0.01 
 
c. significantly elevated apoptosis and degenera-
tion: Of 78 ducts and acini with FBCLD examined, 59 
(75.6%) harbored apoptotic basal cells, compared to 9 
(11.5%) in 78 similar structures with intact basal layers. 
Under high magnification, basal cells near FBCLD of-
ten had cytological signs of degeneration, including 
nuclear swelling, shrinkage, fragmentation, or rod-like 
structures of fused basal cells (Fig. 5). 
 
 
Fig 3. Loss or reduction of p63 expression in focally disrupted basal cell layers. Sections were double immunostained for CK 
34ßE12 (red) and p63 (brown). Thin and thick arrows identify cells with and without p63 expression, respectively. 400X.  
 
Fig 4. Significantly reduced PCNA expression in basal cell layers with FBCLD. Double immunostained for CK34 ßE12 (red) and 
PCNA (brown). Thin and thick arrows identify basal cells with and without PCNA expression, respectively. 400X Int. J. Biol. Sci. 2008, 4 
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Fig 5. Elevated apoptosis and degeneration in focally disrupted basal cell layers. Section was assessed for apoptosis (a-b) or 
CK34βE12 expression (c-d). Arrows identify apoptotic or degenerated basal cells arranged as rod-like structures. 300X.  
d. significantly elevated leukocyte infiltration: In 
sections double immunostained for CK 34ßE12 and 
leukocyte common antigen (LCA), most ducts and 
acini with FBCLD showed leukocyte infiltration, but 
most ducts and acini with non-disrupted layers had no 
leukocyte infiltration (Table 4). Most infiltrated leu-
kocytes were located near FBCLD (Fig 6). 
Table 4. Leukocyte infiltration in ducts or acini with and 
without focal basal cell layer disruption 
Basal cell layer 
status 
 Number of ducts 
or acini 
 Number of leukocyte 
infiltration 
 P 
With focal dis-
ruptions 
 201   183 (91.0%) 
Without focal 
disruptions 
 201   67 (33.3%) 
 
 < 
0.01 
 
 
e. a total loss of the expression of all basal cell 
phenotypic markers: In addition to focal alterations, 
the entire basal cell layer in some ducts and acini 
showed degenerative changes. These basal cell layers 
were morphologically distinct, surrounding PIN or 
normal-appearing duct or acinar clusters (Fig 7). All 
the basal cells, however, lacked the expression of basal 
cell specific markers (Fig 8). In contrast, tumor cells in 
PIN and normal-appearing duct or acinar clusters had 
enlarged nuclei and nucleoli. 
 
 
 
Fig 6. FBCLD and leukocyte infiltration. Double immunostained for CK34ßE12 (red) and LCA (brown). Arrows identify infiltrates 
within EP or near FBCLD. No LCA infiltration was seen in ducts with non-disrupted basal cell layers (asterisks). a; 100X. b: a higher 
(300X) magnification of a.  Int. J. Biol. Sci. 2008, 4 
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Fig 7. Degenerative alterations in entire basal cell layers. Two adjacent sections were H & E (a & b) or immunostained for 
CK34βE12 (c & d). Circles identify PIN. Arrows identify altered basal cell layers in normal appearing acinar clusters. a & c: 100X. 
c & d: 400X. 
 
Fig 8. Morphologically distinct basal cell layers lack expression of all basal cell specific markers. Immunostained for basal (a-e), 
stromal (f), and epithelial (g-h) cell markers. Arrows identify altered basal cell layers. 200X.  
In addition, these basal cell layers were devoid of 
expression of PCNA, in contrast to normal basal cells 
and associated tumor cells, which were strongly posi-
tive for PCNA (Fig. 9). Ducts or acini with altered basal 
cell layers had a significantly higher frequency of mast 
cell infiltration (Fig 9; Table 5). 
  Together, these findings suggest that the basal 
cell layers in these patients have significantly higher 
degenerative alterations. As the basal cell layer is the 
sole source of several tumor suppressors [29-32], de-
generated basal cells are very likely to have impaired 
or reduced functions.  
In contrast to degenerative alterations in basal 
cells, luminal cells overlying FBCLD showed several 
proliferative alterations that were not seen in their ad-
jacent counterparts distant from the disruptions:  
a. significantly elevated cell proliferation: In sec-
tions double immunostained for basal cell phenotypic 
and proliferation-related markers, these clusters had a 
significantly higher proliferation index than their 
counterparts without FBCLD, and most proliferating 
cells were located near FBCLD (Fig.10). Of 78 ducts 
and acini with FBCLD examined, 47 had clusters of 
multiple proliferating cells, compared to 8 in 78 mor-Int. J. Biol. Sci. 2008, 4 
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phologically similar ducts or acini with non-disrupted  basal cell layers (Table 5).  
Table 5. Epithelial proliferation in ducts or acini with and without focal basal cell layer disruption 
Duct or acinar type   Total number   With proliferating cells   P 
With disruption   78   47 (62.5%) 
W/o disruption   78    8 (10.2%) 
 
 < 0.01 
 
 
Fig 9. PNA expression and mast cell infiltration in acini with altered basal cell layers. Double immunostained for CK34 βE12 (red) 
and PCNA (brown) or mast cells (black). Arrows identify basal cell layers or mast cells. a & c: 100X. b & d: 400X. 
 
Fig 10. Increased proliferation in ducts with FBCLD. Sections were double immunostained for CK 34ßE12 (red) and Ki-67 (brown). 
Arrows identify proliferating cell clusters. Note that in a-b, KI-67 positive cells are seen in ducts with FBCLD, but not in adjacent 
ducts without FBCLD (square). a & c: 100X. b & d: a higher (400X) magnification of a and c, respectively. 
b. significantly higher expression of malignancy- and tumor invasion-related molecules: Elevated expres-
sion of prostate specific antigen (PSA) and alpha-methylacyl-CoA racemase (AMACR), are consistently seen in 
cells overlying FBCLD (Fig.11. a & b), and also in normal appearing ducts that lacked the expression of basal cell 
phenotypic markers (Fig. 11 c & d). In contrast, adjacent cells within the same duct, and adjacent ducts with intact 
basal cell layers were largely negative (Fig 11). 
 
c. physical continuity with, and morphological resemblance to, invasive prostate cancer: A vast majority of 
these normal appearing clusters were adjacent to, or blended within, invasive cancers. In some cases, cells over-
lying FBCLD had significantly enlarged nuclei and nucleoli, and were in physical continuity with, or morpho-
logically similar to, their adjacent invasive counterparts (Fig 12). Int. J. Biol. Sci. 2008, 4 
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Fig 11. PSA and AMACR expression in cells overlying FBCLD and ducts with altered basal cells. Double immunostained for CK34 
βE12 (red) and PSA (a-b) or AMACR (c-d) (brown). Thick arrows identify cells with AMACR or PSA expression. Thin arrows 
identify residual basal cells. a & c: 100X. b & d: a higher magnification (400X) of a & c, respectively.  
 
Fig 12. Physical continuity with, and morphological resemblance to, invasive cancer. Double immunostained for CK 34ßE12 (red) 
and Ki-67 (brown). Circles identify proliferating cells overlying FBCLD. Note that cells overlying FBCLD are in direct continuity 
and similar to invasive cancer cells (arrows). a: 100X. b: a higher (400X) magnification of a.  
In some cases, multiple epithelial cell nests appeared to be “budding” from the same acinus or duct (Fig.13). 
These “budding” cells had a higher proliferation and were similar to adjacent invasive cancer cells. The only 
difference was that “budding” cells had residual basal cells (Fig 13, thin arrows). 
d. significantly elevated expression of tumor invasion-related genes: In studies of gene expression profiling, 
cell clusters overlying FBCLD consistently showed significantly higher expression of cell proliferation, apoptosis, 
angiogenesis, immuno-response, and stem cell related genes (Fig 14; Table 6). Int. J. Biol. Sci. 2008, 4 
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Fig 13. Cell “budding” from normal appearing ducts or acini. Double immunostained for CK34ßE12 (red) and Ki-67 (brown). 
Circles identify normal appearing ducts or acini. Thick arrows identify “budding” cell clusters. Thin arrows identify residual basal 
cells. Asterisks identify invasive cancers. a & c: 100X. b & d: a higher (400X) magnification of a and c, respectively. 
 
 
Fig. 14. Different gene expression profiles in cells overlying FBCLD and adjacent counterparts. Cells from these two locations were 
microdissected from frozen prostate sections, and subjected to RNA extraction, amplification, and gene expression profiling using 
our published protocols. Circles identify microdissected cells and differentially expressed genes.  
Table 6. Differentially expressed genes between cells overlying FBCLD and their adjacent cells 
#  Gene name  Potential functions  Fold changes 
1 LIF  Growth  factor  47.37 
2 MCL1  Anti-apoptosis    6.72 
3 TNFRSF7  Anti-apoptosis    7.91 
4  KIT  Stem cell lineage marker   5.03 
5  NCOR2  Stem cell lineage marker   5.45 
6  ENG  Endothelial cell marker   6.38  
7 ICAM2  Endothelial  cell  marker  12.12 Int. J. Biol. Sci. 2008, 4 
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8  KRT17  Epithelial cell marker   7.15 
9 ITGA3  Cell-matrix  adhesion    5.52 
10 ITGB3  Cell-matrix  adhesion    7.14 
11  CCL2  Chemokine, cytokine, and receptor  14.33 
12  CX3CL1  Chemokine, cytokine, and receptor   6.14 
13  CCR1  Chemokine, cytokine, and receptor   5.19 
14  CXCR4  Chemokine, cytokine, and receptor  12.81 
15  TNFRSF10D  TNF receptor family   8.20 
16  TNFRSF12A  TNF receptor family   5.35 
17  TNFRSF25  TNF receptor family   8.52 
18 TIMP1  ECM  inhibitor    5.25 
19 TIMP3  ECM  inhibitor    7.87 
20 MMP-26  Matrix  metalloproteinase  -6.94 
21  IL10  Interleukin and receptor  -9.50 
22  IL12RB2  Interleukin and receptor  -7.02 
23  IL6R  Interleukin and receptor  -7.24 
 
The above alterations were consistently seen in all 
17 cases with a high frequency of FBCLD, while were 
only seen in 1 (9.1%) of the 11 cases with a low fre-
quency of FBCLD, and in none of the 22 cases with 
non-disrupted basal cell layers. Together, these find-
ings suggest that the physical and functional status of 
the basal cell layer significantly impact the biological 
presentation of associated epithelial cells. These find-
ings also suggest that FBCLD may represent a trigger 
factor for prostate tumor progression and invasion.  
To our best knowledge, our findings have not 
been previously reported by others. The most likely 
reasons are: [1] the enzyme theory has dominated the 
direction of researches in the field, and the roles of 
basal cells have been ignored; [2] these alterations 
could be seen only by double immunohistochemistry 
to simultaneously elucidate both basal cells and other 
markers. Double immunostaining, however, has not 
been commonly used in clinical studies.  
The Hypothesis 
  Based on the above findings, we have proposed 
that these normal appearing duct or acinar clusters 
represent a population of maturation arrested tumor 
progenitors derived from monoclonal proliferation of 
genetically damaged primitive stem cells at early 
stages of the prostate morphogenesis probably by 
trauma, radiation, inflammation, or other factors. 
These clusters retain the potential for unlimited cell 
proliferation or multi-lineage differentiation, and 
could progress directly to invasive lesions through two 
different pathways: (1) clonal in situ transformation 
(CIST), and (2) multi-potential progenitor mediated “bud-
ding” (MPMB). These pathways are likely to contribute 
to early onset of prostate cancer at young ages, and to 
biologically and clinically more aggressive prostate 
tumors.  
The Hypothesized Main Steps 
Our hypothesized main steps are the followings:  
1. At the early stage of prostate morphogenesis, 
the prostate of these patients exposed to external or 
internal insults, such as radiation, carcinogens, local-
ized trauma, inflammation, or other factors, which 
caused permanent damages in the DNA structures of 
some primitive stem cells.  
2. Localized DNA structural damages caused the 
inactivation of, or defects, in basal cell renewal-related 
genes, which impaired the basal cell replenishment 
process to replace the aged or injured basal cells, re-
sulting in a “senesced” basal cell population with sig-
nificantly reduced functions.  
3. Localized DNA structural damages also caused 
the inactivation of, or defects in, apoptosis-, or cell 
cycle control related genes in the luminal cell popula-
tion, which allow these cells to escape from pro-
grammed death, to continuously proliferate, and to 
generate their own vascular structures.  
4. Deregulated proliferation in epithelial cells and 
impaired self-renewal in basal cells resulted in the 
overstretch and disassociation of the basal cell layer 
and the BM, which lead to focal breakdown and de-
generation of these two structures.  
5. The degradation products of degenerated basal 
cells and the diffusible molecules of the overlying lu-
minal cells function as self-epitopes to attract migra-
tion and infiltration of immunoreactive cells (IRC) or 
auto-antibodies into the affected sites.  
6. The direct physical contact between IRC and 
degenerated basal cells results in the discharge of the 
digestive enzymes from IRC, leading to the physical 
destruction of altered basal cell layers and the local 
basement membrane, resulting in a focal disruption in 
these structures.  
7. Since the EP is normally devoid of both blood 
vessels and lymphatic ducts, and the basal cell layer is 
the sole source of several tumor suppressors, a FBCLD 
in a given basal cell layer could lead to several focal 
alterations, including: a) A loss or reduction of tumor 
suppressors and the paracrine inhibitory functions, Int. J. Biol. Sci. 2008, 4 
 
255
which allow the luminal cells to undergo elevated 
proliferation [45-49]. b) Alterations in the permeability 
for oxygen or growth factors, which selectively trig-
gers the exit of stem or progenitor cells from quies-
cence, and favor proliferation of cells overlying FBCLD 
[50-52]. c) The exposure of luminal cells to different 
cytokines, which facilitates vasculogenic mimicry and 
tumor angiogenesis [53-54]. d) The physical contact 
between luminal and stromal cells augments the ex-
pression of stromal MMP, facilitating epithe-
lial-mesenchymal transition (EMT) and cell motility 
[55-57]. e) The physical contact between luminal and 
immunoreactive cells directly cause genomic or cellu-
lar damages that trigger a cascade reaction of malig-
nant transformation [58-63].  
8. These alterations could individually or collec-
tively trigger elevated proliferation in luminal cells 
near FBCLD, which leads to the enlargement of 
FBCLD and stretching-out of the residual basal cells. 
Eventually, the entire basal cell layer becomes dissoci-
ated or degenerated (as those shown in Figs. 7-13), 
which facilitates progression of these clusters directly 
to invasive prostate lesions through two different 
mechanisms: a) Clonal in situ transformation (CIST), 
in which the entire luminal cell population of these 
clusters completely lose their surrounding structures 
and transform directly to a new microenvironment 
that favors cell motility and epithelial-mesenchymal 
transition. Although these cells might not possess all 
the properties of invasive cancer cells, the changed 
microenvironment may act as a second “hit” to trigger 
a cascade reaction of malignant transformation that 
rapidly alters the genetic and biochemical profiles of 
these cells. b) Multi-potential progenitor mediated 
“budding”, in which a subset of cell clusters overlying 
FBCLD retain the properties of primitive stem cells. 
Thus, they are able to constantly produce new cells 
and their own vascular structures through “budding” 
(as those shown in Fig.13), representing the source for 
biologically and clinically more aggressive prostate 
tumors.  
9. The above events may occur and progress im-
mediately after the external or internal insults, leading 
to development of prostate cancer at young ages. On 
the other hand, cells of these normal appearing duct or 
acinar clusters may become maturation-arrested after a 
few cycles of cell divisions, and remain idle until a new 
insult [64], representing “bad seeds for bad crops” at 
later ages.   
The Main Differences Between Our Hy-
pothesis And Previous Theories   
Based on our own and other findings, we had 
proposed that prostate tumor invasion is triggered by 
localized degeneration of the basal cells and leukocyte 
infiltration induced auto-immunoreactions, which 
selectively favor monoclonal proliferation and inva-
sion of progenitor or stem cells overlying FBCLD [43]. 
Our hypothesis differs from the traditional theories of 
tumor invasion in 5 aspects: (1) the stage of tumor in-
vasion, (2) the cellular origin of invasive lesions, (3) the 
significance of immunoreactive cells, (4) the signifi-
cance of stromal cells, and (5) the potential approaches 
for interventions and prevention of tumor invasion. 
Our studies of breast tumors have obtained similar 
results and conclusions [65-74]. Our new hypothesis is 
the expansion of our previous one with the following 
new points of views:  
a. the preservation of large clusters of genetically 
damaged stem or progenitor cells: Our previous hy-
pothesis proposes that cell clusters overlying FBCLD 
represent tumor stem or progenitor cells, which un-
dergo a series of immunohistochemical and morphol-
ogic changes, and finally transform into invasive le-
sions [43]. Our current hypothesis suggests that it is 
also possible that multiple genetically damaged primi-
tive stem or progenitor cells within the same site may 
form large duct or acinar clusters that harbor the same 
genetic defects. These clusters may be formed imme-
diately after external or internal insults during the 
early stage of morphogenesis, and progress rapidly, 
leading to early onset of prostate cancer at young ages. 
These clusters could also become maturation arrested 
at patients’ early ages, while they retain the potential 
for unlimited proliferation and multi-lineage differen-
tiation, representing “bad seeds for bad crops” at later 
ages.  
b. direct transformation of the entire duct or 
acinar cluster into invasive lesions:  Our previous 
hypothesis proposes that invasive cells are derived 
exclusively or preferentially from monoclonal prolif-
eration of stem or progenitor cells overlying FBCLD 
[43]. Our current hypothesis suggests that, in addition 
to monoclonal proliferation, it is possible that the en-
tire duct or acinar cluster may directly transform into 
invasive lesions after the disappearance of all sur-
rounding basal cells and the basement membrane.  
c. angiogenesis by genetically altered tumor stem 
cells: Our previous hypothesis proposes that a subset 
of luminal cell clusters overlying FBCLD are in direct 
physical continuity with vascular- or lymphatic 
duct-like structures, which allows them to progress 
directly to metastasis [43]. Our current hypothesis 
further suggests that some normal appearing duct or 
acinar clusters may retain genetically damaged primi-
tive stem cells that could manufacture their own blood 
vessels or lymphatic ducts, which directly lead to me-
tastasis.  Int. J. Biol. Sci. 2008, 4 
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The Significance of Our Hypothesis 
Our hypothesis, if confirmed, could have several 
significant implications. Scientifically, it could lead to a 
new direction to explore novel approaches for early 
detection, intervention, and prevention of prostate 
tumor invasion. For example, as non-disrupted basal 
cell layers have significant inhibitory functions on 
epithelial cell growth, the development of therapeutic 
agents to stimulate basal cell growth or regeneration 
may provide a more effective approach for treatment 
and prevention of prostate cancer invasion. Clinically, 
it could potentially bring the following benefits: 
1. Better recognition of these clusters may avoid 
misdiagnosis and facilitate early interventions, which 
may significantly improve prognosis.   
2. Double immunohistochemical staining to as-
sess the physical integrity of the basal cell layer, or an 
quantitative measurement of basal cell degenera-
tion-related molecules in the blood or biopsies, may 
facilitate early identification of individuals at greater 
risk to develop invasive lesions.   
3. As genetic alterations not only define the scope 
and extent of, but also precede, both biochemical and 
morphological alterations, elucidation of the genetic 
profile of these normal appearing duct or acinar clus-
ters may lead to the identification of the specific 
molecules that trigger the initiation of prostate car-
cinogenesis, progression, and invasion.   
4. Our technical approaches of assessing the 
physical and functional status of the basal cells may be 
used as a more reliable alternative for repeat biopsy to 
monitor prostate tumor progression and invasion.  
More importantly, our hypothesis may be also 
applicable to progression and invasion of other epi-
thelium derived tumors.  
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